Directory · SG
Biotechnology Research in Singapore
A register of firms and the professionals working at them in the Biotechnology Research sector based in Singapore. Browse the public index, then filter or export on Kipplo.
Companies
260 on file
Mmr Consulting
MMR Consulting Inc. and its dedicated team of experienced consultants are committed to delivering high quality, robust solutions for the Pharmaceutical and Biotechnology industries. Our expertise includes Engineering (Process, Automation, Facilities), Capital Project Management of large/complex projects and programs, Commissioning Qualification Validation, and GMP Compliance services.
51 to 200 staff
Lucence
Lucence is a precision health company, using proprietary AI-powered liquid biopsy technology to detect cancers earlier when outcomes are better. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit
51 to 200 staff
A Star Institute Of Molecular And Cell Biology A Star Imcb
The Institute of Molecular and Cell Biology (IMCB) is a premier research institute at A*STAR whose mission is to harness biology for transformational bio-therapeutics and diagnostics. With a strong emphasis on collaboration with stakeholders across the ecosystem in Singapore, IMCB aims to achieve scientific excellence and continues to nurture the next generation of scientists in order to create growth and enhance lives.
201 to 500 staff
Syaqua
Founded in 2001, SyAqua Group, cemented its position as a strong emerging player in commercial shrimp genetics market. Further solidifying SyAqua’s market presence was the acquisition by Gold Coin in 2011 as an independent entity for Gold Coin's hatchery feed operations. In 2022, Ocean 14 Capital obtained a majority share, marking a significant turning point in SyAqua's trajectory to pioneer sustainable shrimp technologies in both genetics and nutritional feed. SyAqua Genetics division has gained significant traction in major Global markets, such as USA, China, India, Indonesia, Thailand, and Malaysia. SyAqua's renowned Balanced Line genetics, is a combination of robustness, higher survival rate, and excellent growth, has excelled across diverse production environments and management systems in Asia. To maintain a competitive edge, SyAqua continues to consistently invest in cutting-edge genetics research and industry experts to ensure a consistent delivery of improved performance. Recently, SyAqua Nutrition inaugurated a state-of-the-art hatchery feed plant, equipped with best-in-class technology, to broaden its range of feeds, thereby fortifying its presence in pivotal markets. This strategic move aims to strengthen SyAqua's position as a major player in hatchery solutions and a leading provider of high-quality early nutrition for shrimp. SyAqua’s robust presence in key markets, is grounded through successful long-term customer relationships accompanied by unrivalled customer service. With a combined management team with over 200 years of collective experience in aquaculture, nutrition, and genetic solutions, SyAqua, dedicates this wealth of expertise to support the thriving success of hatcheries and farms, globally. Together with O14C, SyAqua will pioneer the shrimp industry, creating sustainable shrimp technologies, addressing the needs of shrimp farming today, and ensuring sustainable food security for tomorrow.
201 to 500 staff
Amili
AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health. For more information, visit
11 to 50 staff
Mirxes
Mirxes is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum. We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. We have sales and distribution networks worldwide. Our flagship product is GASTROClear, the world’s first molecular blood test for early detection of gastric cancer, able to detect around 90% of patients with Stage I and II cancers. We continue to build a comprehensive cancer portfolio with early detection tests for lung and thyroid cancer (2022), colorectal and breast cancer (2023), liver and ovarian cancer (2024). We are concurrently building a precision oncology portfolio to provide clinical insights for the complete patient journey. MiRXES was spun off from A*STAR’s Bioprocessing Technology Institute in 2014 to commercialize an industry-leading qPCR-based technology for microRNA detection. Our ID3EAL discovery tool and workflow has been adopted by top academic and industry partners globally and is backed by the world’s first industry standard for microRNA-base diagnostics. Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We are starting with early cancer detection, but we will also be addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases. We responded to COVID-19 by leveraging our capabilities to mass produce and distribute over 5 million units of the Fortitude COVID-19 RT-PCR test. This made-in-Singapore diagnostic test, developed by A*STAR and Tan Tock Seng Hospital, has been deployed in 13 Singapore hospitals and clinical labs and exported to over 45 countries worldwide. Post-COVID, we will leverage this network to commercialize multi-cancer early detection tests.
201 to 500 staff
Cisbay
Cisbay is a bioinnovation company that provides a platform of agricultural products and environmental water treatment solutions globally. Founded in the Silicon Valley, Cisbay embarks on a new global transformation dedicated to restoring soil health and solving the global water crisis. Collaborating with scientists and researchers from several universities and research centers around the world, Cisbay delivers breakthrough technologies which will enhance food supply and precious water resources for future generations. Our mission is to empower farmers to achieve higher yield and cleaner waterways to maximize productivity and profitability through bio-innovative microbial solutions. CISBAY - Bioinnovation for Soil and Water
11 to 50 staff
Cordlife Group Limited
Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets, namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singapore, Hong Kong, the Philippines and Indonesia, Cordlife operates the largest private cord blood banks and it is amongst the top three market leaders in India and Malaysia. In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co, Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh.
501 to 1000 staff
Allozymes
Allozymes is a biotechnology company redefining enzyme engineering through its proprietary ultra-high-throughput microfluidic and AI-driven screening platform. By integrating biocatalysis, enzyme discovery, and microfluidic innovation, we accelerate the development of tailored enzymes for biomanufacturing, pharma, and life sciences. With a vision to build the world’s most comprehensive enzyme data library, Allozymes is enabling faster discovery, smarter optimization, and sustainable production across industries.
11 to 50 staff
Joil Singapore Pte Ltd
JOil Singapore is the world’s only commercial producer of Jatropha for the production of sustainable aviation fuel and other by-products that fuel the bioeconomy. JOil’s plantations in Ghana are a continuous, non-food source of Jatropha nuts for the production of biofuel, bioresin, biochar, bio-briquettes, bio compost etc. JOil holds 5 Patents with Gold Standard and ISCC certifications for its nucleus plantations. JOil has also established a tried and tested model of an outgrowers' program. With nucleus plantations and the outgrower program, JOil ensures a continuous, non-food source supply of Jatropha for the bio-economy. The company strives to mitigate carbon footprint and positively impact the livelihoods of communities through a scientific approach to establishing a Jatropha value chain – from cultivation to downstream applications. The company has established plantations in Ghana, Africa using regenerative agriculture on degraded land with pioneering high-yield Jatropha seeds. JOil addresses very relevant problems facing people and the planet through a pioneering Jatropha value chain and is present in regions with poor capacity and infrastructure. Climate change – Jatropha plantations remove carbon. Jatropha plants, stem and roots sequester carbon for 30 years. Land use & productivity – Jatropha grows on degraded lands and the cultivation of the plant is considered as reforestation. Jatropha is a non-edible feedstock for bio-substitutes and does not disrupt the food chain. Income generation – JOil provides a reliable source of income through employment opportunities for communities in the plantations. Safe and green products – The application of Jatropha for bio substitutes is eco-friendly and uses fewer raw materials in the by-products. Jatropha as feedstock for sustainable aviation fuel helps meet net zero emission targets.
501 to 1000 staff
Profileprint - Ai-Driven Ingredient Quality Platform
ProfilePrint helps global agri-food businesses buy, manufacture and sell better with our patented AI fingerprint technology. By capturing the molecular signature of samples, insights are generated in seconds, enabling stakeholders across the supply chain to make faster and more confident decisions on quality. Based in Singapore, we serve over 60 locations globally and are backed by global VCs and some of the world's largest food companies including Cargill, Louis Dreyfus Company, Olam, Sucafina and Sinar Mas.
11 to 50 staff
Rwdc Industries
RWDC Industries is on a mission to replace petroleum-derived materials with safe, sustainable alternatives. We have developed technology to harvest outputs of a microbial fermentation process using plant-based oils that produces a naturally occurring biodegradable polymer called PHA (or polyhydroxylalkanoate). PHA’s are biopolymers naturally produced by microbial fermentation of plant-based oils or sugar. RWDC’s PHA — Solon — is certified by TÜV Austria to be fully biodegradable in soil, water and marine conditions. Solon is 100% biodegradable with no toxic residue. Solon is a global solution to today’s plastic waste management challenge, and it's an ideal material for replacing petroleum-derived, single-use plastics — such as cutlery, cups, bags, plates and bowls. Solon safely biodegrades in natural environments, leaving absolutely no harmful remains or byproducts.
51 to 200 staff
Auristone Pte Ltd
Auristone is an Asian-based epigenomic profiling company powered with data analytics capabilities and extensive epigenomic know-how. We use our comprehensive portfolio of Asian epigenomic database to power data-driven drug and biomarker discoveries. EPI-Call™ is our Flagship second generation Next Generation Sequencing (NGS) test. In addition to genomic information (DNA-seq), EPI-Call™ further provides epigenomic information around the tumour micro-environment and predicts patient response to immunotherapy. EPI-Call™ is the pragmatic choice to aid physicians in deciding the best treatment option for their patients. We are committed to supporting clinical and academic epigenomic research, and moving such research outcomes into the clinical setting. Driven by our aspiration to improve the quality of life for patients through better treatment, we are continuously seeking ways to bring our technologies to our clinical and academic partners. For more information on the company, drop us a line at enquiry@auristone.com or visit our website at
1 to 10 staff
Biomax Green Pte Ltd
Biomax Green is a leading biotechnology company built on a fundamental belief that the world is our community and we have the responsibility to put the needs of our people, communities and the environment first. After years of intensive research, we successfully revolutionised the global organic waste treatment industry with our innovative breakthrough technology. Characterised by a relentless pursuit of innovation, quality, and safety and beyond all things organic, we continue to be at the forefront of creating a sustainable and green ecosystem both locally and internationally.
11 to 50 staff
Cellresearch Corporation
CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we have started USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing.
11 to 50 staff
Cordlife Singapore
Listed on the Main Board of the Singapore Exchange ("SGX"), Cordlife Group Limited ("Cordlife", and together with its subsidiaries, the "Group") is presently a service provider of umbilical cord blood and cord lining banking. The first cord blood bank to be set up in Singapore (May 2001) and amongst the first in Asia, Cordlife Group Limited has more than 16 years of cord blood banking experience as well as a published track record of cord blood transplants. The Group currently owns and operates full processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines. Cordlife's processing and storage facilities in Singapore, Hong Kong and India are AABB accredited and by late 2015, the Singapore facility achieved accreditation from FACT-Netcord, placing the Group as one of the six international private cord blood banks that hold accreditations by two world-class standards. Besides being the first private cord blood bank in Southeast Asia to enjoy the dual-accreditation status, the Group also extends its products and services to families in the region through its associate in Thailand and sub-licensing partner in China.*Conditional accreditation status for Cordlife’s facility in Singapore
51 to 200 staff
Cryoviva Singapore
Established in early 2014, Cryoviva Singapore has successfully stored many samples of local and expat clients, and is managed and maintained by a team of experts. We have an extensive list of happy parents who have trusted our services and stored their baby’s cord blood with us. As a group, Cryoviva has more than cord blood units successfully stored in our regional facilities. Cryoviva affiliated companies have well established and highly accredited operations in umbilical cord stem cell banking in India and Thailand. In Singapore, we have our own MoH licensed laboratory that demonstrates stringent processes and high-quality standards to ensure each sample is handled and processed with utmost care. Our Singapore facility is very centrally located, so it requires even lesser time for the sample to reach our labs from most maternity hospitals.
51 to 200 staff
Dotbio
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit
1 to 10 staff
Ecolex Animal Nutrition
Founded in 2005, Ecolex Animal Nutrition is a global leader in innovative animal nutrition, with expertise embedded in molecular engineering and bioscience. We are dedicated to developing sustainable solutions that enhance productivity while minimizing environmental impact. Ecolex has become established as a leading manufacturer and supplier of specialty rumen bypass and rumen inert fats for the global dairy farming business. From our state-of-the-art production facility near Port Klang, Malaysia, we serve an extensive export market, supplying to more than 35 countries across five continents. Today, our core expertise is focused in 3 key areas: • Emulsification Technologies: We lead the industry in advanced emulsification techniques that improve nutrient bioavailability and feed efficiency. • Advanced Lipid Nutrition: Our specialists develop optimized fatty acid balances to enhance animal health and performance. • Sustainable Insect Proteins: We pioneer the production of alternative protein sources that support eco-friendly practices.
201 to 500 staff
Esco
Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries. Our Vision Strategically positioned to bridge the East and West, Esco aspires to become the leading provider of life science and fertility tools, delivering sustainable technologies that foster a healthier, more equitable, and resilient future. Our Mission We provide cutting-edge, sustainable workflow solutions that empower scientists and innovators to advance global health and enhance quality of life. ROOTED IN VALUES; DRIVEN BY SUCCESS
1001 to 5000 staff
Atlantis Bioscience Pte Ltd
Atlantis Bioscience Pte Ltd is a Singapore-based manufacturer and distributor of cell culture reagents and lab equipment started in 2016. We take pride in our transparent and customer-oriented work culture. Our team is not bounded by the archaic rules to be at a desk. The best ideas may not even come in an office. Our customers and partners require swift service and solutions. As such, we strive to incorporate cloud solutions and equip our team with the latest technologies to help customers across several markets. Our mission is to facilitate global customers access to good products or technologies which may be unknown to them. Singapore is geographically well placed for us to help our partners in a very short turnaround time in Asia.
1 to 10 staff
Biocon Solutions Pte Ltd
About Us- Biocon Solutions is a Singapore headquartered company which was started in 2004. We are pharma engineers partnering with leading containment specialist to provide an integrated solution for pharma and life science industries. We have our offices in India, Indonesia, Malaysia and Thailand. The USP of Biocon is the strength of our technical team wherein we provide the installation and qualification for the equipments we supply. It is our endeavor to strive hard to bring the best of our solutions, cost effective to our clients that has made us successful in this competitive market. Vision – 1. To become a leading pharma service provider in the global life science market. Continuously improving through technology upgradation and employee training. Mission- 1. We are committed to provide high quality engineering services to exceed customer satisfaction. To make a positive contribution to the world by delivering environment friendly services/products.
11 to 50 staff
Cerecin
Cerecin is a global healthcare company with more than 20 years of innovation and leadership in brain health. At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.
11 to 50 staff
Deltafrontier
DeltaFrontier PTE LTD (“DF”), a Singapore based value added solution company; In this Era of globalization, when technologies evolve rapidly.Deltafrontier is strategically well-positioned to lead at the forefront of cutting-edge AIoT technologies. With Deltafrontier, you can expect reduced execution cost, proven risk mitigation strategies and industry-specific technical advice with wide sourcing excellence.
1 to 10 staff
